VF
CKPT

Virtu Financial’s Checkpoint Therapeutics CKPT Stock Holding History

Virtu Financial’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,157
Closed -$122K – 1440
2024
Q4 		$122K Buy
38,157
+24,552
+180% +$83.2K 0.01% 980
2024
Q3 		$30K Buy
+13,605
New +$31.4K ﹤0.01% 1079
2022
Q3 		– Sell
-4,978
Closed -$51K – 1780
2022
Q2 		$51K Buy
+4,978
New +$65.2K ﹤0.01% 1124
2021
Q4 		– Sell
-1,672
Closed -$55K – 1767
2021
Q3 		$55K Buy
+1,672
New +$49.4K ﹤0.01% 1256
2021
Q2 		– Sell
-2,646
Closed -$83K – 1573
2021
Q1 		$83K Buy
2,646
+525
+25% +$17.6K 0.01% 1363
2020
Q4 		$56K Sell
2,121
-914
-30% -$23.1K 0.01% 1209
2020
Q3 		$81K Buy
3,035
+1,624
+115% +$39K 0.01% 747
2020
Q2 		$28K Buy
+1,411
New +$25.7K ﹤0.01% 1093
2019
Q3 		– Sell
-1,606
Closed -$49K – 1464
2019
Q2 		$49K Buy
+1,606
New +$63K ﹤0.01% 1242

Other funds holding CKPT

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return

Virtu Financial's CKPT Position: Q1 2025 in Review

Virtu Financial sold out of Checkpoint Therapeutics (CKPT) in Q1 2025, closing a stake of 38,157 shares — an estimated $122K sold.

Virtu Financial first reported a position in CKPT in Q2 2019 and held it in 9 quarters. The position peaked at $122K in Q4 2024. 84 funds tracked by Wall St. Rank hold CKPT as of Q1 2025.

  • Virtu Financial reported no remaining Checkpoint Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 38,157 Checkpoint Therapeutics shares in Q1 2025, an estimated $122K.
  • Virtu Financial first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 9 quarters.
  • Virtu Financial's Checkpoint Therapeutics position peaked at $122K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.